Citadel Advisors LLC 13D and 13G filings for Protagonist Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:58 pm Sale |
2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
Citadel Advisors LLC | 390,512 0.700% |
-2,292,302 (-85.44%) |
Filing |
| 2023-01-03 4:22 pm Purchase |
2022-12-21 | 13G | Protagonist Therapeutics, Inc. PTGX |
Citadel Advisors LLC | 2,682,814 5.500% |
2,682,814 (New Position) |
Filing |